The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 35,367,866 | 2,412,542 | SH | SOLE | 2,412,542 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 11,036,536 | 232,446 | SH | SOLE | 232,446 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 1,390,550 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 4,498,074 | 175,706 | SH | SOLE | 175,706 | 0 | 0 | |||
| AURA BIOSCIENCES INC | COM | 05153U107 | 3,538,520 | 572,576 | SH | SOLE | 572,576 | 0 | 0 | |||
| CELLECTIS S A | SPON ADS | 15117K103 | 9,352,278 | 3,281,501 | SH | SOLE | 3,281,501 | 0 | 0 | |||
| ELI LILLY & CO | COM | 532457108 | 17,167,500 | 22,500 | SH | Put | SOLE | 22,500 | 0 | 0 | ||
| GAMESQUARE HLDGS INC | COM | 36468G103 | 169,700 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 22,754 | 158 | SH | SOLE | 158 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 3,255,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| NRX PHARMACEUTICALS INC | *W EXP 05/24/202 | 629444118 | 4,455,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| NVIDIA CORPORATION | COM | 67066G104 | 13,993,500 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 1,442,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 1,669,500 | 31,500 | SH | SOLE | 31,500 | 0 | 0 | |||
| REPLIMUNE GROUP INC | COM | 76029N106 | 209,500 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
| SIGHT SCIENCES INC | COM | 82657M105 | 3,199,200 | 930,000 | SH | SOLE | 930,000 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,676,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 5,887,818 | 1,800,556 | SH | SOLE | 1,800,556 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 4,060,800 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
| ZAI LAB LTD | ADR | 98887Q104 | 13,556,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||